Study Stopped
terminated due to PI lab/duties affected by natural disaster.
Bone Disease in Severely Burned Children
1 other identifier
interventional
254
1 country
1
Brief Summary
Bone metabolism is adversely affected by severe burns in children for a period of time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Oct 1992
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 1992
CompletedFirst Submitted
Initial submission to the registry
December 26, 2007
CompletedFirst Posted
Study publicly available on registry
January 11, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2008
CompletedJune 6, 2014
June 1, 2014
15.7 years
December 26, 2007
June 5, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Determine Bone Health(bone growth,strength,and content) in burn injured patients.
Admission to Burn Unit up to eighteen years old.
Study Arms (1)
1
ACTIVE COMPARATORCompare bone density of severly burned children to normal non-burned population
Interventions
Two courses of IV Tetracycline(10mg./kg./day for two days)separated by a two week interval.
DEXA before discharge from acute admission and again one year post burn.
Bone biopsy to be taken in the operation room at the last skin grafting operation at the site of the iliac crest. A second bone biopsy will be taken one year later post discharge from the acute admission.
Eligibility Criteria
You may qualify if:
- Children age 5-18 years old with at least 40% or more of their body burned.
You may not qualify if:
- Anyone with a burn covering less than 40% of the body or whose burn covers the front of both hipbones.
- Anyone younger than 5 years old, anyone with a history of cancer or other metabolic disease process, or anyone who is pregnant or has an allergy to Tetracycline will also be excluded.
- Anyone who has participated in an investigational drug trial within the past 60 days from date of admission will be excluded from this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
U.T.M.B.
Galveston, Texas, 77550, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Klein Gordon, M.D.
U.T.M.B.
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 26, 2007
First Posted
January 11, 2008
Study Start
October 1, 1992
Primary Completion
June 1, 2008
Study Completion
June 1, 2008
Last Updated
June 6, 2014
Record last verified: 2014-06